SEC Info℠  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Becton Dickinson & Co. – ‘10-Q’ for 3/31/22 – ‘EX-101.SCH’

On:  Thursday, 5/5/22, at 11:57am ET   ·   For:  3/31/22   ·   Accession #:  10795-22-40   ·   File #:  1-04802

Previous ‘10-Q’:  ‘10-Q’ on 2/3/22 for 12/31/21   ·   Next:  ‘10-Q’ on 8/4/22 for 6/30/22   ·   Latest:  ‘10-Q’ on 5/2/24 for 3/31/24   ·   3 References:   

Find Words in Filings emoji
 		  in    Show  and   ↓Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

 5/05/22  Becton Dickinson & Co.            10-Q        3/31/22   61:7.1M

Quarterly Report   —   Form 10-Q

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML    783K 
 2: EX-22       Published Report re: Matters Submitted to a Vote    HTML     18K 
                of Security Holders                                              
 3: EX-31       Certification -- §302 - SOA'02                      HTML     27K 
 4: EX-32       Certification -- §906 - SOA'02                      HTML     21K 
10: R1          Cover Page                                          HTML     99K 
11: R2          Condensed Consolidated Statements of Income         HTML     97K 
12: R3          Condensed Consolidated Statements of Comprehensive  HTML     48K 
                Income                                                           
13: R4          Condensed Consolidated Balance Sheets               HTML    135K 
14: R5          Condensed Consolidated Statements of Cash Flows     HTML     84K 
15: R6          Basis of Presentation                               HTML     24K 
16: R7          Shareholders' Equity                                HTML    169K 
17: R8          Earnings Per Share                                  HTML     37K 
18: R9          Contingencies                                       HTML     40K 
19: R10         Revenues                                            HTML     28K 
20: R11         Segment Data                                        HTML    152K 
21: R12         Benefit Plans                                       HTML     42K 
22: R13         Business Restructuring Charges                      HTML     31K 
23: R14         Intangible Assets                                   HTML     63K 
24: R15         Derivative Instruments and Hedging Activities       HTML     51K 
25: R16         Financial Instruments and Fair Value Measurements   HTML     47K 
26: R17         Debt                                                HTML     26K 
27: R18         Contingencies (Policies)                            HTML     42K 
28: R19         Shareholders' Equity (Tables)                       HTML    166K 
29: R20         Earnings Per Share (Tables)                         HTML     37K 
30: R21         Segment Data (Tables)                               HTML    150K 
31: R22         Benefit Plans (Tables)                              HTML     37K 
32: R23         Business Restructuring Charges (Tables)             HTML     30K 
33: R24         Intangible Assets (Tables)                          HTML     65K 
34: R25         Derivative Instruments and Hedging Activities       HTML     45K 
                (Tables)                                                         
35: R26         Financial Instruments and Fair Value Measurements   HTML     46K 
                (Tables)                                                         
36: R27         Shareholders' Equity - Changes in Certain           HTML     89K 
                Components of Shareholders' Equity (Details)                     
37: R28         Shareholders' Equity - Accumulated Other            HTML     43K 
                Comprehensive Income (Loss) - Components and                     
                Changes of Accumulated Other Comprehensive Income                
                (Loss) (Detail)                                                  
38: R29         Earnings Per Share - Weighted Average Common        HTML     38K 
                Shares Used in Computations of Basic and Diluted                 
                Earnings per Share (Detail)                                      
39: R30         Contingencies (Detail)                              HTML     30K 
40: R31         Revenues (Details)                                  HTML     30K 
41: R32         Segment Data - Additional Information (Detail)      HTML     20K 
42: R33         Segment Data - Revenues by Geographic Areas         HTML     91K 
                (Detail)                                                         
43: R34         Segment Data - Financial Information for Company's  HTML     55K 
                Segments (Detail)                                                
44: R35         Benefit Plans (Detail)                              HTML     42K 
45: R36         Business Restructuring Charges (Detail)             HTML     31K 
46: R37         Intangible Assets - Components of Intangible        HTML     46K 
                Assets (Detail)                                                  
47: R38         Intangible Assets - Additional Information          HTML     21K 
                (Detail)                                                         
48: R39         Intangible Assets - Reconciliation of Goodwill by   HTML     37K 
                Business Segment (Detail)                                        
49: R40         Derivative Instruments and Hedging Activities -     HTML     30K 
                Additional Information (Detail)                                  
50: R41         Derivative Instruments and Hedging Activities -     HTML     34K 
                Schedule of Notional Amounts of Outstanding                      
                Derivative Positions (Detail)                                    
51: R42         Derivative Instruments and Hedging Activities       HTML     29K 
                Disclosure - Gains (Losses) on Net Investment                    
                Hedges (Details)                                                 
52: R43         Financial Instruments and Fair Value Measurements   HTML     28K 
                - Cash and Equivalents and Restricted Cash                       
                (Details)                                                        
53: R44         Financial Instruments and Fair Value Measurements   HTML     24K 
                - Schedule of Fair Value, Assets and Liabilities                 
                Measured on Recurring Basis (Details)                            
54: R45         Financial Instruments and Fair Value Measurements   HTML     28K 
                - Additional Information (Detail)                                
55: R46         Financial Instruments and Fair Value Measurements   HTML     23K 
                - Transfer of Financial Assets Accounted for as                  
                Sales (Details)                                                  
56: R47         Debt (Detail)                                       HTML     52K 
59: XML         IDEA XML File -- Filing Summary                      XML    106K 
57: XML         XBRL Instance -- bdx-20220331_htm                    XML   2.27M 
58: EXCEL       IDEA Workbook of Financial Reports                  XLSX     74K 
 6: EX-101.CAL  XBRL Calculations -- bdx-20220331_cal                XML    146K 
 7: EX-101.DEF  XBRL Definitions -- bdx-20220331_def                 XML    407K 
 8: EX-101.LAB  XBRL Labels -- bdx-20220331_lab                      XML   1.12M 
 9: EX-101.PRE  XBRL Presentations -- bdx-20220331_pre               XML    623K 
 5: EX-101.SCH  XBRL Schema -- bdx-20220331                          XSD    111K 
60: JSON        XBRL Instance as JSON Data -- MetaLinks              325±   439K 
61: ZIP         XBRL Zipped Folder -- 0000010795-22-000040-xbrl      Zip    235K

‘EX-101.SCH’   —   XBRL Schema — bdx-20220331

This Exhibit is an XBRL XML File.

                                                                                                                                                                                
<?xml version="1.0" encoding="windows-1252"?>
<!-- XBRL Document Created with Wdesk from Workiva -->
<!-- Copyright 2022 Workiva -->
<!-- r:e602671e-4fe1-4961-adbb-f9dd82a282de,g:36534b56-6db4-48ab-9f63-2a72d6bb30f2 -->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:bdx="http://www.bd.com/20220331" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.bd.com/20220331">
<xs:import namespace="http://fasb.org/srt/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd"/>
<xs:import namespace="http://fasb.org/us-gaap/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd"/>
<xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
<xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
<xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
<xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
<xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
<xs:import namespace="http://xbrl.sec.gov/country/2021" schemaLocation="https://xbrl.sec.gov/country/2021/country-2021.xsd"/>
<xs:import namespace="http://xbrl.sec.gov/dei/2021" schemaLocation="https://xbrl.sec.gov/dei/2021/dei-2021.xsd"/>
<xs:import namespace="http://xbrl.sec.gov/exch/2021" schemaLocation="https://xbrl.sec.gov/exch/2021/exch-2021.xsd"/>
<xs:import namespace="http://xbrl.sec.gov/stpr/2021" schemaLocation="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd"/>
<xs:annotation>
<xs:appinfo>
<link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="bdx-20220331_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
<link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="bdx-20220331_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
<link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="bdx-20220331_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
<link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="bdx-20220331_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
<link:roleType id="CoverPage" roleURI="http://www.bd.com/role/CoverPage">
<link:definition> 0001001 - Document - Cover Page </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="CondensedConsolidatedStatementsofIncome" roleURI="http://www.bd.com/role/CondensedConsolidatedStatementsofIncome">
<link:definition> 1001002 - Statement - Condensed Consolidated Statements of Income </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="CondensedConsolidatedStatementsofComprehensiveIncome" roleURI="http://www.bd.com/role/CondensedConsolidatedStatementsofComprehensiveIncome">
<link:definition> 1002003 - Statement - Condensed Consolidated Statements of Comprehensive Income </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="CondensedConsolidatedBalanceSheets" roleURI="http://www.bd.com/role/CondensedConsolidatedBalanceSheets">
<link:definition> 1003004 - Statement - Condensed Consolidated Balance Sheets </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="CondensedConsolidatedStatementsofCashFlows" roleURI="http://www.bd.com/role/CondensedConsolidatedStatementsofCashFlows">
<link:definition> 1004005 - Statement - Condensed Consolidated Statements of Cash Flows </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="BasisofPresentation" roleURI="http://www.bd.com/role/BasisofPresentation">
<link:definition> 2101101 - Disclosure - Basis of Presentation </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="ShareholdersEquity" roleURI="http://www.bd.com/role/ShareholdersEquity">
<link:definition> 2102102 - Disclosure - Shareholders' Equity </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="ShareholdersEquityTables" roleURI="http://www.bd.com/role/ShareholdersEquityTables">
<link:definition> 2303301 - Disclosure - Shareholders' Equity (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="ShareholdersEquityChangesinCertainComponentsofShareholdersEquityDetails" roleURI="http://www.bd.com/role/ShareholdersEquityChangesinCertainComponentsofShareholdersEquityDetails">
<link:definition> 2404401 - Disclosure - Shareholders' Equity - Changes in Certain Components of Shareholders' Equity (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="ShareholdersEquityAccumulatedOtherComprehensiveIncomeLossComponentsandChangesofAccumulatedOtherComprehensiveIncomeLossDetail" roleURI="http://www.bd.com/role/ShareholdersEquityAccumulatedOtherComprehensiveIncomeLossComponentsandChangesofAccumulatedOtherComprehensiveIncomeLossDetail">
<link:definition> 2405402 - Disclosure - Shareholders' Equity - Accumulated Other Comprehensive Income (Loss) - Components and Changes of Accumulated Other Comprehensive Income (Loss) (Detail) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="EarningsPerShare" roleURI="http://www.bd.com/role/EarningsPerShare">
<link:definition> 2106103 - Disclosure - Earnings Per Share </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="EarningsPerShareTables" roleURI="http://www.bd.com/role/EarningsPerShareTables">
<link:definition> 2307302 - Disclosure - Earnings Per Share (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="EarningsPerShareWeightedAverageCommonSharesUsedinComputationsofBasicandDilutedEarningsperShareDetail" roleURI="http://www.bd.com/role/EarningsPerShareWeightedAverageCommonSharesUsedinComputationsofBasicandDilutedEarningsperShareDetail">
<link:definition> 2408403 - Disclosure - Earnings Per Share - Weighted Average Common Shares Used in Computations of Basic and Diluted Earnings per Share (Detail) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="Contingencies" roleURI="http://www.bd.com/role/Contingencies">
<link:definition> 2109104 - Disclosure - Contingencies </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="ContingenciesPolicies" roleURI="http://www.bd.com/role/ContingenciesPolicies">
<link:definition> 2210201 - Disclosure - Contingencies (Policies) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="ContingenciesDetail" roleURI="http://www.bd.com/role/ContingenciesDetail">
<link:definition> 2411404 - Disclosure - Contingencies (Detail) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="Revenues" roleURI="http://www.bd.com/role/Revenues">
<link:definition> 2112105 - Disclosure - Revenues </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="RevenuesDetails" roleURI="http://www.bd.com/role/RevenuesDetails">
<link:definition> 2413405 - Disclosure - Revenues (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="RevenuesDetails_1" roleURI="http://www.bd.com/role/RevenuesDetails_1">
<link:definition> 2413405 - Disclosure - Revenues (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="SegmentData" roleURI="http://www.bd.com/role/SegmentData">
<link:definition> 2114106 - Disclosure - Segment Data </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="SegmentDataTables" roleURI="http://www.bd.com/role/SegmentDataTables">
<link:definition> 2315303 - Disclosure - Segment Data (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="SegmentDataAdditionalInformationDetail" roleURI="http://www.bd.com/role/SegmentDataAdditionalInformationDetail">
<link:definition> 2416406 - Disclosure - Segment Data - Additional Information (Detail) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="SegmentDataRevenuesbyGeographicAreasDetail" roleURI="http://www.bd.com/role/SegmentDataRevenuesbyGeographicAreasDetail">
<link:definition> 2417407 - Disclosure - Segment Data - Revenues by Geographic Areas (Detail) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="SegmentDataFinancialInformationforCompanysSegmentsDetail" roleURI="http://www.bd.com/role/SegmentDataFinancialInformationforCompanysSegmentsDetail">
<link:definition> 2418408 - Disclosure - Segment Data - Financial Information for Company's Segments (Detail) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="BenefitPlans" roleURI="http://www.bd.com/role/BenefitPlans">
<link:definition> 2119107 - Disclosure - Benefit Plans </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="BenefitPlansTables" roleURI="http://www.bd.com/role/BenefitPlansTables">
<link:definition> 2320304 - Disclosure - Benefit Plans (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="BenefitPlansDetail" roleURI="http://www.bd.com/role/BenefitPlansDetail">
<link:definition> 2421409 - Disclosure - Benefit Plans (Detail) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="BusinessRestructuringCharges" roleURI="http://www.bd.com/role/BusinessRestructuringCharges">
<link:definition> 2122108 - Disclosure - Business Restructuring Charges </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="BusinessRestructuringChargesTables" roleURI="http://www.bd.com/role/BusinessRestructuringChargesTables">
<link:definition> 2323305 - Disclosure - Business Restructuring Charges (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="BusinessRestructuringChargesDetail" roleURI="http://www.bd.com/role/BusinessRestructuringChargesDetail">
<link:definition> 2424410 - Disclosure - Business Restructuring Charges (Detail) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="IntangibleAssets" roleURI="http://www.bd.com/role/IntangibleAssets">
<link:definition> 2125109 - Disclosure - Intangible Assets </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="IntangibleAssetsTables" roleURI="http://www.bd.com/role/IntangibleAssetsTables">
<link:definition> 2326306 - Disclosure - Intangible Assets (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="IntangibleAssetsComponentsofIntangibleAssetsDetail" roleURI="http://www.bd.com/role/IntangibleAssetsComponentsofIntangibleAssetsDetail">
<link:definition> 2427411 - Disclosure - Intangible Assets - Components of Intangible Assets (Detail) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="IntangibleAssetsAdditionalInformationDetail" roleURI="http://www.bd.com/role/IntangibleAssetsAdditionalInformationDetail">
<link:definition> 2428412 - Disclosure - Intangible Assets - Additional Information (Detail) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="IntangibleAssetsReconciliationofGoodwillbyBusinessSegmentDetail" roleURI="http://www.bd.com/role/IntangibleAssetsReconciliationofGoodwillbyBusinessSegmentDetail">
<link:definition> 2429413 - Disclosure - Intangible Assets - Reconciliation of Goodwill by Business Segment (Detail) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="DerivativeInstrumentsandHedgingActivities" roleURI="http://www.bd.com/role/DerivativeInstrumentsandHedgingActivities">
<link:definition> 2130110 - Disclosure - Derivative Instruments and Hedging Activities </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="DerivativeInstrumentsandHedgingActivitiesTables" roleURI="http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesTables">
<link:definition> 2331307 - Disclosure - Derivative Instruments and Hedging Activities (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="DerivativeInstrumentsandHedgingActivitiesAdditionalInformationDetail" roleURI="http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesAdditionalInformationDetail">
<link:definition> 2432414 - Disclosure - Derivative Instruments and Hedging Activities - Additional Information (Detail) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="DerivativeInstrumentsandHedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetail" roleURI="http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetail">
<link:definition> 2433415 - Disclosure - Derivative Instruments and Hedging Activities - Schedule of Notional Amounts of Outstanding Derivative Positions (Detail) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="DerivativeInstrumentsandHedgingActivitiesDisclosureGainsLossesonNetInvestmentHedgesDetails" roleURI="http://www.bd.com/role/DerivativeInstrumentsandHedgingActivitiesDisclosureGainsLossesonNetInvestmentHedgesDetails">
<link:definition> 2434416 - Disclosure - Derivative Instruments and Hedging Activities Disclosure - Gains (Losses) on Net Investment Hedges (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="FinancialInstrumentsandFairValueMeasurements" roleURI="http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurements">
<link:definition> 2135111 - Disclosure - Financial Instruments and Fair Value Measurements </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="FinancialInstrumentsandFairValueMeasurementsTables" roleURI="http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementsTables">
<link:definition> 2336308 - Disclosure - Financial Instruments and Fair Value Measurements (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="FinancialInstrumentsandFairValueMeasurementsCashandEquivalentsandRestrictedCashDetails" roleURI="http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementsCashandEquivalentsandRestrictedCashDetails">
<link:definition> 2437417 - Disclosure - Financial Instruments and Fair Value Measurements - Cash and Equivalents and Restricted Cash (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="FinancialInstrumentsandFairValueMeasurementsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails" roleURI="http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails">
<link:definition> 2438418 - Disclosure - Financial Instruments and Fair Value Measurements - Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="FinancialInstrumentsandFairValueMeasurementsAdditionalInformationDetail" roleURI="http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementsAdditionalInformationDetail">
<link:definition> 2439419 - Disclosure - Financial Instruments and Fair Value Measurements - Additional Information (Detail) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="FinancialInstrumentsandFairValueMeasurementsTransferofFinancialAssetsAccountedforasSalesDetails" roleURI="http://www.bd.com/role/FinancialInstrumentsandFairValueMeasurementsTransferofFinancialAssetsAccountedforasSalesDetails">
<link:definition> 2440420 - Disclosure - Financial Instruments and Fair Value Measurements - Transfer of Financial Assets Accounted for as Sales (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="Debt" roleURI="http://www.bd.com/role/Debt">
<link:definition> 2141112 - Disclosure - Debt </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="DebtDetail" roleURI="http://www.bd.com/role/DebtDetail">
<link:definition> 2442421 - Disclosure - Debt (Detail) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
</xs:appinfo>
</xs:annotation>
<xs:element id="bdx_MedicationDeliverySolutionsMember" abstract="true" name="MedicationDeliverySolutionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
<xs:element id="bdx_HerniaProductClaimsMember" abstract="true" name="HerniaProductClaimsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
<xs:element id="bdx_Notes0000DueAugust132023Member" abstract="true" name="Notes0000DueAugust132023Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
<xs:element id="bdx_Notes1.208dueJune42026Member" abstract="true" name="Notes1.208dueJune42026Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
<xs:element id="bdx_Notes5000DueFebruary152030Member" abstract="true" name="Notes5000DueFebruary152030Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
<xs:element id="bdx_CoreAndDevelopedTechnologyNet" abstract="false" name="CoreAndDevelopedTechnologyNet" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
<xs:element id="bdx_IncreaseDecreaseinPensionBenefitObligation" abstract="false" name="IncreaseDecreaseinPensionBenefitObligation" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
<xs:element id="bdx_FiniteAndIndefiniteLivedIntangibleAssetsTable" abstract="true" name="FiniteAndIndefiniteLivedIntangibleAssetsTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
<xs:element id="bdx_BiosciencesMember" abstract="true" name="BiosciencesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
<xs:element id="bdx_InterventionalMember" abstract="true" name="InterventionalMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
<xs:element id="bdx_StockRepurchaseProgramNumberOfAdditionalSharesAuthorizedToBeRepurchased" abstract="false" name="StockRepurchaseProgramNumberOfAdditionalSharesAuthorizedToBeRepurchased" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
<xs:element id="bdx_OrganizationalUnitDomain" abstract="true" name="OrganizationalUnitDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
<xs:element id="bdx_FixedToFloatingMember" abstract="true" name="FixedToFloatingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
<xs:element id="bdx_ProductRightsMember" abstract="true" name="ProductRightsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
<xs:element id="bdx_FiniteAndIndefiniteLivedIntangibleAssetsLineItems" abstract="true" name="FiniteAndIndefiniteLivedIntangibleAssetsLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
<xs:element id="bdx_Notes1213NotesDueFebruary122036Member" abstract="true" name="Notes1213NotesDueFebruary122036Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
<xs:element id="bdx_ProductsandorServicesMember" abstract="true" name="ProductsandorServicesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
<xs:element id="bdx_Notes1.401dueMay242023Member" abstract="true" name="Notes1.401dueMay242023Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
<xs:element id="bdx_PharmaceuticalSystemsMember" abstract="true" name="PharmaceuticalSystemsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
<xs:element id="bdx_PeripheralInterventionMember" abstract="true" name="PeripheralInterventionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
<xs:element id="bdx_UrologyandCriticalCareMember" abstract="true" name="UrologyandCriticalCareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
<xs:element id="bdx_Notes1.000dueDecember152022Member" abstract="true" name="Notes1.000dueDecember152022Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
<xs:element id="bdx_FiniteLivedCustomerRelationshipsNet" abstract="false" name="FiniteLivedCustomerRelationshipsNet" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
<xs:element id="bdx_TermLoanFacilityMember" abstract="true" name="TermLoanFacilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
<xs:element id="bdx_ProceedsfromIssuanceofLongTermDebtandTermLoans" abstract="false" name="ProceedsfromIssuanceofLongTermDebtandTermLoans" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
<xs:element id="bdx_SurgeryMember" abstract="true" name="SurgeryMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
<xs:element id="bdx_MedicalMember" abstract="true" name="MedicalMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
<xs:element id="bdx_TransfersOfFinancialAssetsDuringThePeriod" abstract="false" name="TransfersOfFinancialAssetsDuringThePeriod" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
<xs:element id="bdx_CommonStockSharesHeldInEmployeeTrust1" abstract="false" name="CommonStockSharesHeldInEmployeeTrust1" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
<xs:element id="bdx_CommonStockHeldInTrustsAcquired" abstract="false" name="CommonStockHeldInTrustsAcquired" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
<xs:element id="bdx_Notes6750DueFebruary152030Member" abstract="true" name="Notes6750DueFebruary152030Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
<xs:element id="bdx_CommonStockHeldInTrustsNetShares" abstract="false" name="CommonStockHeldInTrustsNetShares" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
<xs:element id="bdx_OrganizationalUnitAxis" abstract="true" name="OrganizationalUnitAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
<xs:element id="bdx_FloatingRateNotesDueJune62022Member" abstract="true" name="FloatingRateNotesDueJune62022Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
<xs:element id="bdx_ForeignCurrencyDenominatedDebtMember" abstract="true" name="ForeignCurrencyDenominatedDebtMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
<xs:element id="bdx_Notes0.632dueJune42023Member" abstract="true" name="Notes0.632dueJune42023Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
<xs:element id="bdx_Notes3.020dueMay242025Member" abstract="true" name="Notes3.020dueMay242025Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
<xs:element id="bdx_DiabetesCareMember" abstract="true" name="DiabetesCareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
<xs:element id="bdx_IntegratedDiagnosticSolutionsMember" abstract="true" name="IntegratedDiagnosticSolutionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
<xs:element id="bdx_ShareBasedCompensationMember" abstract="true" name="ShareBasedCompensationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
<xs:element id="bdx_ConsumablesMember" abstract="true" name="ConsumablesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
<xs:element id="bdx_MaturityPeriodOfShortTermInvestment" abstract="false" name="MaturityPeriodOfShortTermInvestment" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
<xs:element id="bdx_MedicationManagementSolutionsMember" abstract="true" name="MedicationManagementSolutionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
<xs:element id="bdx_NumberOfEtOSterilizationLawsuitsFiled" abstract="false" name="NumberOfEtOSterilizationLawsuitsFiled" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
<xs:element id="bdx_LifeSciencesMember" abstract="true" name="LifeSciencesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
<xs:element id="bdx_AcquisitionRelatedCostsAndRestructuringCharges" abstract="false" name="AcquisitionRelatedCostsAndRestructuringCharges" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
<xs:element id="bdx_Notes1.900dueDecember152026Member" abstract="true" name="Notes1.900dueDecember152026Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
<xs:element id="bdx_FairValueOfDebtClassifiedFromLongTermToShortTerm" abstract="false" name="FairValueOfDebtClassifiedFromLongTermToShortTerm" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
<xs:element id="bdx_Notes0034DueAugust132025Member" abstract="true" name="Notes0034DueAugust132025Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
<xs:element id="bdx_ContractWithCustomerRebateLiability" abstract="false" name="ContractWithCustomerRebateLiability" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
</xs:schema>

2 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 8/10/22  Becton, Dickinson & Co.           424B2                  2:946K                                   Broadridge Fin’l So… Inc
 8/08/22  Becton, Dickinson & Co.           424B2                  1:923K                                   Broadridge Fin’l So… Inc

1 Previous Filing that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 3/21/22  Becton, Dickinson & Co.           8-K:3,5,8,9 3/16/22   13:314K                                   Donnelley … Solutions/FA
↑Top
Filing Submission 0000010795-22-000040   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)
Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
About — Privacy — Redactions — Help — Sat., May 11, 10:00:21.2pm ET